What research is FRAXA funding in 2025? Join us for a live webinar where FRAXA Co-Founders Dr. Michael Tranfaglia and Katie Clapp will present an overview of all Fragile X research grants awarded so far this year. From novel therapeutic strategies to innovative models of Fragile X syndrome, each project represents a step forward in our mission to accelerate effective treatments. Whether you’re a scientist, clinician, or part of the Fragile X community, this session offers a comprehensive view of where the field is heading — and who’s driving it. » Learn what’s being funded » Understand research priorities » Get your questions answered in real time #FragileX #NeuroscienceResearch #RareDiseaseInnovation (fb)

Dr. Jeannie Lee, a leading researcher at Harvard Medical School and Massachusetts General Hospital, has been awarded a $1 million Blavatnik Therapeutics Challenge Award to expand her innovative work reactivating the gene that fails to function in Fragile X syndrome. This award builds on years of research funded by FRAXA and is one of the most competitive funding programs at Harvard Medical School, designed to fast-track promising science toward real-world treatments. It also means that FRAXA can fund the next essential steps in Dr. Lee’s research. Stay tuned! #FragileX #TranslationalResearch (fb)